Póster presentada en el IX Simposi de Neurobiologia Experimental, celebrado los días 22 y 23 de octubre de 2014 en Barcelona y organizado por la Societat Catalana de Biologia del Institut d'Estudis CatalansRecent basic and clinical studies suggest a main role of the glutamate system in the pathophysiology of depression. However, the precise mechanism by which glutamate modulates mood and emotions remains unknown. Neuroimaging studies have reported functional and metabolic alterations in the medial prefrontal cortex (mPFC) of depressed patients -particularly in its ventral regions- and these abnormalities are hypothesized to result from glial dysfunction, as shown in rodent and human studies. The current studies were conducted to determine ...
Novel fast-acting antidepressant strategies, such as ketamine and deep brain stimulation, enhance gl...
Novel fast-acting antidepressant strategies, such as ketamine and deep brain stimulation, enhance gl...
Glutamate neurotransmission dysfunction is increasingly considered a core feature of mental illnesse...
Trabajo presentado en el 16th National Congress of the Spanish Society of Neuroscience (SENC), celeb...
Ketamine and deep brain stimulation produce rapid antidepressant effects in humans and rodents. An i...
[Background] Glutamatergic neurotransmission has emerged as a novel target in antidepressant drug de...
Major depressive disorder (MDD) is a leading cause of disability worldwide, with a poorly known path...
Trabajo presentado en el X Simposi de Neurobiologia, celebrado en Barcelona, España, el 6 y 7 de oct...
Trabajo presentado en el ECNP Workshop for Junior Scientists in Europe, celebrado en Niza, Francia, ...
Trabajo presentado en el 10th FENS Forum of Neuroscience (FENS 2016), celebrado en Copenhague, Dinam...
Trabajo presentado en el Neuroscience 2017, celebrado en Washington del 11 al 15 de noviembre de 201...
Trabajo presentado en el 28th ECNP Congress, celebrado en Ámsterdam, Países Bajos, del 29 de agosto ...
Deep brain stimulation (DBS) is a treatment that has shown some efficacy in treatment-resistant depr...
Background: Glutamatergic neurotransmission has emerged as a novel target in antidepressant drug dev...
Recent compelling evidence has suggested that the glutamate system is a primary mediator of psychiat...
Novel fast-acting antidepressant strategies, such as ketamine and deep brain stimulation, enhance gl...
Novel fast-acting antidepressant strategies, such as ketamine and deep brain stimulation, enhance gl...
Glutamate neurotransmission dysfunction is increasingly considered a core feature of mental illnesse...
Trabajo presentado en el 16th National Congress of the Spanish Society of Neuroscience (SENC), celeb...
Ketamine and deep brain stimulation produce rapid antidepressant effects in humans and rodents. An i...
[Background] Glutamatergic neurotransmission has emerged as a novel target in antidepressant drug de...
Major depressive disorder (MDD) is a leading cause of disability worldwide, with a poorly known path...
Trabajo presentado en el X Simposi de Neurobiologia, celebrado en Barcelona, España, el 6 y 7 de oct...
Trabajo presentado en el ECNP Workshop for Junior Scientists in Europe, celebrado en Niza, Francia, ...
Trabajo presentado en el 10th FENS Forum of Neuroscience (FENS 2016), celebrado en Copenhague, Dinam...
Trabajo presentado en el Neuroscience 2017, celebrado en Washington del 11 al 15 de noviembre de 201...
Trabajo presentado en el 28th ECNP Congress, celebrado en Ámsterdam, Países Bajos, del 29 de agosto ...
Deep brain stimulation (DBS) is a treatment that has shown some efficacy in treatment-resistant depr...
Background: Glutamatergic neurotransmission has emerged as a novel target in antidepressant drug dev...
Recent compelling evidence has suggested that the glutamate system is a primary mediator of psychiat...
Novel fast-acting antidepressant strategies, such as ketamine and deep brain stimulation, enhance gl...
Novel fast-acting antidepressant strategies, such as ketamine and deep brain stimulation, enhance gl...
Glutamate neurotransmission dysfunction is increasingly considered a core feature of mental illnesse...